Replies to post #1637 on RespireRx Pharmaceuticals Inc (RSPI)

[meixatech]

OT - Thanks, Aiming & gfp.

gfp – you appear to be saying that it is not the product, but the crappy environment we are currently in for novel cancer therapies. I am basing a very big bucket of my noodles on a simple interpretation on that February news release: patients are surviving longer with EP-2101 than without. Isn't this what makes or breaks a cancer drug? If anyone has a different interpretation of that news release, I sure would like to hear it. Or is it that one just cannot believe a news release from a company that is on nobody's radar screen? I really need a reason (like proof of actually (and previously suggested by my wife), “being in La-La Land”) to dump.

Aiming, I will keep on topic from now on. Thank you for your patience.